Please login to the form below

Not currently logged in
Email:
Password:

Integrated Medhealth Communication group acquires Script Medical Writing

The Canadian group brings a wealth of scientific writing expertise to IMC

IMCIndependent medical communications agency Integrated Medhealth Communication (IMC) has acquired Toronto-based Script Medical Writing as part of the expansion plans for its North American office.

London-headquartered IMC is looking to the deal to boost its scientific writing expertise and talent as well as bring what it says will be a significant number of new pharmaceutical and biotech clients.

Shairose Ebrahim, founder and CEO of the IMC group, said: “I am delighted to welcome the Script team to IMC NA. This acquisition is a testament to our unprecedented growth and success in the North American market and will strengthen our position as a leader in scientific communications globally.”

Script was established in 1998 and has developed medical content including peer-reviewed journals and abstracts, posters and presentations for international congress across multiple therapy areas.

“Increasing our scientific writing expertise through Script, combined with our capabilities in developing innovative medical communications solutions, will provide added value to our clients and enable us to help them achieve greater success with their brands and communication programmes,” said Dr Azhar Rana, vice president and managing director of IMC North America.

Article by
Gemma Jones

13th July 2017

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
COUCH Health

We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...

Latest intelligence

WHITE PAPER 05: Improving the effectiveness of clinical trial recruitment materials
With exclusive research conducted by COUCH Health, gain insight into clinical trial recruitment materials best practice....
COVID-19: the race to find a vaccine
How biopharma is working to bring an end to the pandemic...
Guiding star of science leads AstraZeneca to breakthrough in child tumour therapy
Global product lead George Kirk hails the triumph of selumetinib, which has just won FDA approval...

Infographics